Analytical Validation of Illumina’s TSO500 ctDNA Assay

Get in Touch

Our Locations

Analytical Validation of Illumina’s TSO500 ctDNA Assay

Presentation given at the Illumina Corporate Workshop at AMP 2019

This presentation provides an overview of Illumina's TruSight Oncology 500 (TSO500) panel and discusses the analytical validation of the TSO500 ctDNA assay (pre-release version).
Download the presentation to learn more.

Related Services & Solutions

Related Thought Leaders Insights

Scientific Poster

A new ELISpot/FluoroSpot best practice using a novel lyophilized FBS for clinical immune monitoring assays

Interferon gamma (IFN) ELISpot and FluoroSpot are widely used immune monitoring assays to detect functional cell responses in clinical studies. Recognized for their importance in vaccine development...

Podcast

What is the Role of Digital Pathology in Clinical Trials

In this episode, Dr. Monika Lamba, a pathologist from Q² Solutions, discusses the transformative role of digital pathology in clinical trials. Despite its origins aiming to streamline trials, it's...

Brochure

Vaccine Laboratory Services

With emerging and re-emerging infectious diseases, the development of new anti-infectives and vaccines presents many challenges. Q² Solutions understands these challenges in vaccine development. Our...